Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05258136
What this trial is testing

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

Who this might be right for
PTLDCAEBVHLH
Beijing Friendship Hospital 20
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Early research (Phase 1)Study completedNCT01523223
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)+31 more
Robert Lowsky 16
Early research (Phase 1)UnknownNCT00003920
What this trial is testing

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of California, Davis 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07598110
What this trial is testing

FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 77
Testing effectiveness (Phase 2)Looking for participantsNCT07228624
What this trial is testing

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmPrimary MyelofibrosisSecondary Myelofibrosis
Fred Hutchinson Cancer Center 50
Early research (Phase 1)Study completedNCT01087294
What this trial is testing

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, B-cellLymphoma, HodgkinsLymphoma, Non-hodgkins+1 more
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Looking for participantsNCT03970096
What this trial is testing

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Fred Hutchinson Cancer Center 120
Not applicableStudy completedNCT03323541
What this trial is testing

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Who this might be right for
Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma
University Hospital, Brest 62
Testing effectiveness (Phase 2)UnknownNCT00311337
What this trial is testing

VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)

Who this might be right for
Multiple Myeloma
University of Wuerzburg 61
Testing effectiveness (Phase 2)WithdrawnNCT01620229
What this trial is testing

Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic/Lymphoid Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00048464
What this trial is testing

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Who this might be right for
Multiple Myeloma
Xcyte Therapies 35
Not applicableStudy completedNCT03032016
What this trial is testing

European VOD Registry

Who this might be right for
Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT02210078
What this trial is testing

Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 49
Not applicableActive Not RecruitingNCT05634512
What this trial is testing

Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.

Who this might be right for
Hematopoietic Cell TransplantationMucopolysaccharidosis Type I
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Looking for participantsNCT05525507
What this trial is testing

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

Who this might be right for
End Stage Kidney DiseaseImmunological ToleranceKidney Transplant Failure and Rejection+1 more
University of California, Los Angeles 10
Early research (Phase 1)Study completedNCT00343798
What this trial is testing

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+86 more
Fred Hutchinson Cancer Center 23
Testing effectiveness (Phase 2)UnknownNCT03821519
What this trial is testing

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant

Who this might be right for
Relapsed Hematologic Malignancy
A.O. Ospedale Papa Giovanni XXIII 20
Early research (Phase 1)Active Not RecruitingNCT03118492
What this trial is testing

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

Who this might be right for
Secondary Myelofibrosis
City of Hope Medical Center 22
Next Page